title: Does high-dose cytarabine cause cumulative toxicity in patients undergoing consolidation therapy for acute myeloid leukemia?
authors.forename: Andres
authors.initials: A
authors.lastname: Wiernik
authors.forename: Wolfgang R
authors.initials: WR
authors.lastname: Sperr
authors.forename: Daniel
authors.initials: D
authors.lastname: Weisdorf
authors.forename: Peter
authors.initials: P
authors.lastname: Valent
authors.forename: Celalettin
authors.initials: C
authors.lastname: Ustun
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects; D060830:Consolidation Chemotherapy; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D012074:Remission Induction
chemical_list: D000964:Antimetabolites, Antineoplastic; D007166:Immunosuppressive Agents; D003561:Cytarabine